Profile | GDS2987 / GI_18860905-S |
Title | Comparison of Rho kinase inhibitor and atorvastatin effects on primary cell lines |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM214810 | HMVEC_vehicle_rep1 | 3.5 | 13 |
GSM215244 | HMVEC_vehicle_rep2 | 10.3 | 27 |
GSM215253 | HMVEC_vehicle_rep3 | ||
GSM215254 | HMVEC_atorvastatin_rep1 | ||
GSM215282 | HMVEC_atorvastatin_rep3 | 4.9 | 12 |
GSM215344 | HMVEC_atorvastatin_rep2 | 8 | 20 |
GSM215283 | HMVEC_atorvastatin_mevalonate_rep1 | ||
GSM215284 | HMVEC_atorvastatin_mevalonate_rep2 | ||
GSM215293 | HMVEC_atorvastatin_mevalonate_rep3 | 5.1 | 9 |
GSM215294 | HMVEC_SLx2119_rep1 | 9.5 | 33 |
GSM215295 | HMVEC_SLx2119_rep2 | ||
GSM215296 | HMVEC_SLx2119_rep3 | ||
GSM215297 | PASMC_vehicle_rep1 | 415.9 | 87 |
GSM215298 | PASMC_vehicle_rep2 | 398.7 | 87 |
GSM215310 | PASMC_vehicle_rep3 | 536.7 | 90 |
GSM215311 | PASMC_atorvastatin_rep1 | 675.6 | 91 |
GSM215312 | PASMC_atorvastatin_rep2 | 575.2 | 90 |
GSM215313 | PASMC_atorvastatin_rep3 | 626.7 | 90 |
GSM215324 | PASMC_atorvastatin_mevalonate_rep1 | 589.3 | 90 |
GSM215325 | PASMC_atorvastatin_mevalonate_rep2 | 549.8 | 89 |
GSM215326 | PASMC_atorvastatin_mevalonate_rep3 | 543.7 | 90 |
GSM215327 | PASMC_SLx2119_rep1 | 2388 | 97 |
GSM215328 | PASMC_SLx2119_rep2 | 2224.4 | 97 |
GSM215329 | PASMC_SLx2119_rep3 | 2085.5 | 97 |
GSM215330 | Fibroblasts_vehicle_rep1 | 29.7 | 54 |
GSM215331 | Fibroblasts_vehicle_rep2 | 23.2 | 52 |
GSM215332 | Fibroblasts_vehicle_rep3 | 22.5 | 56 |
GSM215333 | Fibroblasts_atorvastatin_rep1 | 21.7 | 49 |
GSM215334 | Fibroblasts_atorvastatin_rep2 | 16.7 | 42 |
GSM215335 | Fibroblasts_atorvastatin_rep3 | 3.5 | 9 |
GSM215336 | Fibroblasts_atorvastatin_mevalonate_rep1 | 21 | 54 |
GSM215337 | Fibroblasts_atorvastatin_mevalonate_rep2 | 28.7 | 62 |
GSM215338 | Fibroblasts_atorvastatin_mevalonate_rep3 | 16.7 | 43 |
GSM215339 | Fibroblasts_SLx2119_rep1 | 4.7 | 14 |
GSM215340 | Fibroblasts_SLx2119_rep2 | ||
GSM215341 | Fibroblasts_SLx2119_rep3 | 29.5 | 57 |